The authors also demonstrated the immunomodulatory effects of the treatment of human U251 and TG1 glioblastoma cells with both flavoinds, negatively modulating the expression of mRNA for IL-6 and IL-10 and positively the expression of mRNA for TNF. The gene discussed is IL6; the disease is glioblastoma.